Newborn Screening for the Diagnosis and Treatment of Duchenne Muscular Dystrophy

被引：6

作者：

Farrar, Michelle A. ^{[1
,2
]}

Kariyawasam, Didu ^{[1
,2
]}

Grattan, Sarah ^{[1
,2
]}

Bayley, Klair ^{[3
]}

Davis, Mark ^{[4
]}

Holland, Sandra ^{[1
,2
]}

Waddel, Leigh B. ^{[5
,6
,7
]}

Jones, Kristi ^{[5
]}

Lorentzos, Michelle ^{[6
,7
,8
]}

Ravine, Anja ^{[9
]}

Wotton, Tiffany ^{[9
]}

Wiley, Veronica ^{[9
]}

机构：

[1] Sydney Childrens Hosp Network, Dept Paediat Neurol, Sydney, NSW, Australia

[2] UNSW Sydney, UNSW Med & Hlth, Sch Clin Med, Discipline Paediat, Sydney, NSW, Australia

[3] Univ Western Australia, Harry Perkins Inst Med Res, Nedlands, WA, Australia

[4] QEII Med Ctr, Dept Diagnost Genom, PathWest Lab Med, Perth, WA, Australia

[5] Univ Sydney, Fac Med & Hlth, Sydney Med Sch, Discipline Child & Adolescent Hlth, Sydney, NSW, Australia

[6] Childrens Hosp Westmead, TY Nelson Dept Neurol & Neurosurg, Sydney, NSW, Australia

[7] Childrens Hosp Westmead, Kids Neurosci Ctr, Westmead, NSW, Australia

[8] Univ Sydney, Discipline Paediat, Sydney, NSW, Australia

[9] Childrens Hosp Westmead, NSW Newborn Screening Programme, Westmead, NSW, Australia

来源：

JOURNAL OF NEUROMUSCULAR DISEASES | 2023年 / 10卷 / 01期

基金：

英国医学研究理事会;

关键词：

Duchenne muscular dystrophy; newborn screening; presymptomatic; implementation; translation; PARENTAL ATTITUDES; EXPERIENCE; MANAGEMENT; EMERGENCY; BENEFIT; CARE;

D O I：

10.3233/JND-221535

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

A pilot newborn screening (NBS) program for Duchenne muscular dystrophy (DMD) study proposes to assess the feasibility of the screening procedure, temporal course of the various steps of screening, and the public acceptability of the program. This is particularly vital to ascertain as DMD is considered a `non-treatable' disease and thus does not fit the traditional criteria for newborn screening. However, modern perspectives of NBS for DMD are changing and point to possible net benefits for children and their families undertaking NBS for DMD. The aim of this workshop was to establish pathways for the successful implementation and evaluation of a pilot NBS for DMD program in Australia. Consensus was reached as to the rationale for, potential benefits, risks, barriers and facilitators of screening, alongside the establishment of screening protocols and clinical referral pathways.

引用

页码：15 / 28

页数：14

共 50 条

[31] Early diagnosis of Duchenne muscular dystrophy - A Treat-NMD international workshop
Lorentzos, M.
Parsons, J. A.
Jones, K. J.
Servais, L.
NEUROMUSCULAR DISORDERS, 2024, 45
[32] Treatment effect of idebenone on inspiratory function in patients with Duchenne muscular dystrophy
Buyse, Gunnar M.
Voit, Thomas
Schara, Ulrike
Straathof, Chiara S. M.
D'Angelo, Maria Grazia
Bernert, Guenther
Cuisset, Jean-Marie
Finkel, Richard S.
Goemans, Nathalie
Rummey, Christian
Leinonen, Mika
Mayer, Oscar H.
Spagnolo, Paolo
Meier, Thomas
McDonald, Craig M.
PEDIATRIC PULMONOLOGY, 2017, 52 (04) : 508 - 515
[33] Testosterone Treatment of Pubertal Delay in Duchenne Muscular Dystrophy
Wood, Claire L.
Cheetham, Tim D.
Guglieri, Michela
Bushby, Kate
Owen, Catherine
Johnstone, Helen
Straub, Volker
NEUROPEDIATRICS, 2015, 46 (06) : 371 - 376
[34] Update on Duchenne muscular dystrophy
Leiva-Cepas, F.
Montano Martinez, A.
Lopez-Lopez, I
MEDICINA DE FAMILIA-SEMERGEN, 2021, 47 (07): : 472 - 481
[35] Is it the right time for an infant screening for Duchenne muscular dystrophy?
Gian Luca Vita
Giuseppe Vita
Neurological Sciences, 2020, 41 : 1677 - 1683
[36] Two years of newborn screening for Duchenne muscular dystrophy as a part of the statewide Early Check research program in North Carolina
Kucera, Katerina S.
Boyea, Beth Lincoln
Migliore, Brooke
Potter, Sarah Nelson
Robles, Veronica R.
Kutsa, Oksana
Cope, Heidi
Okoniewski, Katherine C.
Wheeler, Anne
Rehder, Catherine W.
Smith, Edward C.
Peay, Holly L.
GENETICS IN MEDICINE, 2024, 26 (01)
[37] Is it the right time for an infant screening for Duchenne muscular dystrophy?
Vita, Gian Luca
Vita, Giuseppe
NEUROLOGICAL SCIENCES, 2020, 41 (07) : 1677 - 1683
[38] Consensus on the diagnosis, treatment and follow-up of patients with Duchenne muscular dystrophy
Nascimento Osorio, A.
Medina Cantillo, J.
Camacho Salas, A.
Madruga Garrido, M.
Vilchez Padilla, J. J.
NEUROLOGIA, 2019, 34 (07): : 469 - 481
[39] Duchenne Muscular Dystrophy in Kazakhstan: A Journey from Diagnosis to the Treatment, the Biases and Achievements
Jaxybayeva, Altynshash
Chunkayeva, Dana
Myrzaliyeva, Bakhytkul
Ayaganov, Dinmukhamed
Lepessova, Marzhan
Bulekbayeva, Sholpan
Idrissova, Zhannat
Mukhambetova, Gulnar
Bayanova, Mirgul
Malfatti, Edoardo
Urtizberea, Andoni
JOURNAL OF NEUROMUSCULAR DISEASES, 2023, 10 (02) : 263 - 269
[40] Emerging Strategies in the Treatment of Duchenne Muscular Dystrophy
Shieh, Perry B.
NEUROTHERAPEUTICS, 2018, 15 (04) : 840 - 848

← 1 2 3 4 5 →